ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2022 American Transplant Congress

    Recipient Neutrophil Production of Myeloperoxidase is Required for NK Cell Activation During Acute Antibody Mediated Allograft Rejection

    Y. Mitsui1, D. Ueda1, S. Miyairi1, N. Dvorina1, K. S. Keslar1, A. Valujskikh1, B. William1, R. Fairchild2

    1Inflammation & Immunity, Cleveland Clinic, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: Dysregulated donor-specific antibody (DSA) responses are induced in B6.CCR5-/- mice transplanted with complete MHC mismatched A/J kidney allografts and are required for rejection of…
  • 2022 American Transplant Congress

    Repeat Kidney Transplantation from Living Donors Offers Comparable Outcomes as First Transplantation

    N. Oh, K. Lee, J. Rhu, J. Kim, G. Choi, J. Park, J. Joh

    Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: The number of patients relisted for repeat kidney transplantation is increasing due to prolonged survival after first transplantation. This study is designed to compare…
  • 2022 American Transplant Congress

    Dialysis Patient Perspectives on Obesity as a Barrier to Kidney Transplantation

    S. S. Hingorany, A. Klassen, B. Milliron, J. Sweeting, J. Lee, R. HaileSelasse, B. Gunen, M. N. Harhay

    Drexel University, Philadelphia, PA

    *Purpose: Although obesity is a known barrier to kidney transplantation (KT) and associated with delayed graft function and graft loss, guidance is lacking on optimal…
  • 2022 American Transplant Congress

    Longitudinal Analysis of Donor-Derived Cell-Free DNA (dd-cfDNA) in En-Bloc Kidney Transplantation

    S. K. Akkina1, J. Klein2, A. Khalil3, G. Shekhtman4, S. Patel4, N. Agrawal4, M. Fei4, N. Singh5, A. Desai1

    1Loyola University Medical Center, Maywood, IL, 2University of Kansas Medical Center, Kansas City, KS, 3Dallas Nephrology Associates, Dallas, TX, 4CareDx, Brisbane, CA, 5Willis Knighton Health System, Shreveport, LA

    *Purpose: The longitudinal dd-cfDNA patterns in en-bloc kidney transplant recipients have not been studied. It is unknown how the initial smaller mass of the two…
  • 2022 American Transplant Congress

    Autophagy is an Important Factor in the Development of Fibrosis Following Renal Injury; Implications for Post-Transplant IFTA

    R. Lopez-Soler1, X. Ding2, Q. Zang3

    1Tansplant, Surgery, Edward Hines VA Medical Center, Hines, IL, 2Pathology, Loyola University Medical Center, Maywood, IL, 3Surgery, Loyola University Medical Center, Maywood, IL

    *Purpose: Interstitial Fibrosis and Tubular Atrophy (IFTA) is the most common cause of long-term graft failure following renal transplant. There is currently no effective therapy.…
  • 2022 American Transplant Congress

    Estrogen Receptor Beta Deletion is Protective in Renal Ischemia Reperfusion Injury but Pharmacologic Inhibition of Estrogen Receptor Beta is Not

    C. OBrien1, P. Hernandez2, S. Concors2, Z. Wang1, G. Ge1, W. Hancock3, M. Levine2

    1Surgery, University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Childrens Hospital of Philadelphia, Philadelphia, PA

    *Purpose: Renal Ischemia Reperfusion Injury (IRI) contributes substantially to delayed graft function (DGF) in kidney transplantation. Prior work by our group has shown lower rates…
  • 2022 American Transplant Congress

    Patient Preferences for Waiting Time and Kidney Quality: A Discrete Choice Experiment

    S. Mehrotra

    Industrial Engineering and Management Sciences, Northwestern University, Evanston, IL

    *Purpose: The purpose of this study was to elicit patient preferences involving tradeoffs between a lower quality kidney offered today and a higher quality, future…
  • 2022 American Transplant Congress

    Post-Kidney Transplant Valacyclovir versus Valganciclovir for CMV Prophylaxis: A Randomized Controlled Trial

    P. S. Verghese1, A. Matas2, S. Chinnakotla2, M. Evans3, H. Balfour Jr4

    1Univ of Minnesota Pediatric Nephrology, Minneapolis, MN, 2Surgery, University of Minnesota Medical School, Minneapolis, MN, 3Biostatistics, University of Minnesota, Minneapolis, MN, 4Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN

    *Purpose: Valganciclovir (valG) is an effective CMV prophylactic agent post-kidney transplant (KTx) with significant side effects. Valacyclovir (valA) may be effective for CMV prophylaxis with…
  • 2022 American Transplant Congress

    Comparing Long-Term Outcomes of Steroid-Based versus Steroid-Avoidant Immunosuppression in Pediatric Kidney Transplant Recipients

    N. Hayde1, E. Blanchette2, J. Zhang3, M. Chandran2, M. Bock2, S. Galbiati3, T. Blydt-Hansen4

    1Montefiore Medical Center, Bronx, NY, 2Children's Hospital Colorado, Aurora, CO, 3Emmes Corporation, Rockville, MD, 4University of British Columbia, Vancouver, BC, Canada

    *Purpose: With increasing use of potent immunosuppressant (IS) medications, steroid-avoidant (SA) regimens are now commonly used for pediatric kidney transplant recipients (pKTs) to avoid potential…
  • 2022 American Transplant Congress

    Higher Immunogenicity of a Third Heterologous Dose with BNT262b2 Mensanger RNA Vaccine Compared to a Homologous Dose in Kidney Transplant Recipients Fully Vaccinated with Inactivated Whole-Virion CoronaVac Vaccine

    L. V. Pouzo1, M. Nakamura1, L. A. Viana2, E. Lucena1, M. Jesus1, G. Bittencourt Pereira Lima1, J. Medina1, H. Tedesco1, M. Cristelli1

    1Hospital do Rim, Universidade Federal de São Paulo, São Paulo, Brazil, 2Nephrology, Hospital do rim, Sao Paulo, Brazil

    *Purpose: This study aims to compare the immunogenicity of a third dose of the heterologous BNT262b2 mRNA vaccine versus the homologous inactivated whole-virion CoronaVac vaccine…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences